S-adenosylmethionine in the treatment of depression

The antidepressant property of S-adenosylmethionine (SAMe) has been supported by several uncontrolled and controlled studies. Compared to standard antidepressant agents, SAMe has fewer side-effects and shorter lag period. Future studies to delineate SAMe-responsive depression are warranted.

Saved in:
Bibliographic Details
Published inNeuroscience and biobehavioral reviews Vol. 12; no. 2; p. 139
Main Authors Vahora, S A, Malek-Ahmadi, P
Format Journal Article
LanguageEnglish
Published United States 1988
Subjects
Clinical Trials as Topic
Depressive Disorder - drug therapy
Humans
S-Adenosylmethionine - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:The antidepressant property of S-adenosylmethionine (SAMe) has been supported by several uncontrolled and controlled studies. Compared to standard antidepressant agents, SAMe has fewer side-effects and shorter lag period. Future studies to delineate SAMe-responsive depression are warranted.
ISSN:0149-7634
DOI:10.1016/S0149-7634(88)80005-8